Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NOVO NORDISK INC. via NOVO NORDISK INC.
2013 · second_quarter · Q2
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Source: Senate LDA
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Safeguarding America's Pharmaceuticals Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
Global Investment in American Jobs Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Global Investment in American Jobs Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Protecting Seniors' Access to Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Access to Quality Diabetes Education Act of 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
Pharmaceutical Quality, Security, and Accountability Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011, H.R. 8 American Taxpayer Relief Actof 2012, and H.R. 1588 and S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Physician Quality and Reporting System (PQRS)
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
HR 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
H.R. 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit); H.R. 2052 and S. 1023 Global Investment in American Jobs Act
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Safeguarding America's Pharmaceuticals Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
BPCA and PREA Reauthorization Act of 2012
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
To correct and improve certain provisions of the Leahy-Smith America Invents Act and title 35, United States Code.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
HR 6621 Technical corrections to the America Invents Act; S. 3486, the Patent Law Treaties Implementation Act of 2012
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Preventing Diabetes in Medicare Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
Temporary Payroll Tax Cut Continuation Act of 2011
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; issues regarding comparative effectiveness
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: NOVO NORDISK INC. · Firm: NOVO NORDISK INC.
H.R. 1, American Recovery and Reinvestment Act of 2009, H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; issues regarding comparative effectiveness
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013 and S.959 Pharmaceutical Compounding Quality and Accountability Act (for track and trace supply chain provisions); issues regarding biosimilars; 340B
Issues related to insulin pen safety and access in the VA
Issues related to patent litigation and patent assertion entities (PAEs) aka patent trolls
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H. Con. Res. 25 House Budget Resolution; H.R. 2663 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring estimates with respect to preventive health legislation); National Diabetes Prevention Program in H.R. 933 -- FY13 Consolidated and Further Continuing Appropriations Act and S. 1284 FY14 Depts. of Labor, Health and Human Services, and Education Appropriations Act
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP) (intellectual property)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
NOVO NORDISK INC. via NOVO NORDISK INC.
2013 · first_quarter · Q1
HR 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit)
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP); intellectual property
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · fourth_quarter · Q4
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act
H.R. 436 Protect Medical Innovation Act of 2011; HR 8 American Taxpayer Relief Act of 2012 (R&D credit)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
P.L. 112-186, SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
HR 6621 Technical corrections to the America Invents Act; S. 3486, the Patent Law Treaties Implementation Act of 2012
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction) and HR 8 American Taxpayer Relief Act of 2012
Trans-Pacific Partnership (TPP): biosimilar provisions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, Special Diabetes Program reauthorization, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care in the Essential Health Benefits Package, IOM Committee on Valuing Community-Based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to CBO scoring of preventive health legislation); and National Diabetes Prevention Program
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
Trans-Pacific Partnership (TPP): biosimilar provisions
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · second_quarter · Q2
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); Issues related to modernizing cost estimates with respect to preventive health legislation (scoring) and National Diabetes Prevention Program
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
Trans-Pacific Partnership (TPP): biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
H.R. 436 Protect Medical Innovation Act of 2011
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
NOVO NORDISK INC. via NOVO NORDISK INC.
2012 · first_quarter · Q1
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · fourth_quarter · Q4
P.L. 112-29 (H.R. 1249 and S. 23), America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · third_quarter · Q3
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program, CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · second_quarter · Q2
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, and Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package
NOVO NORDISK INC. via NOVO NORDISK INC.
2011 · first_quarter · Q1
H.R. 1249 and S. 23, America Invents Act
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: issues related to the 340B program
Modernizing criminal laws concerning theft of medical products
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · fourth_quarter · Q4
H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; issues regarding comparative effectiveness
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 1995, S. 844, Eliminating Disparities in Diabetes Prevention Access and Care Act and the Diabetes in Minority Populations Evaluations Act; H.R. 3090, Health Equity and Accountability Act; P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, issues related to minority health
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · third_quarter · Q3
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
H.R. 3148, the Preventive Health Savings Act
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · second_quarter · Q2
Supporting increasing opportunities for better care and treatment of people with diabetes in H.R. 3590 Patient Protection and Affordable Care Act of 2009; H.R. 4872, The Health Care & Education Affordability Reconciliation Act Of 2010, entire bill, including Prevention and Wellness titles
H.R. 1, American Recovery and Reinvestment Act of 2009, H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; issues regarding comparative effectiveness
H.R. 3148, the Preventive Health Savings Act
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · first_quarter · 1A
Issues related to Medicaid rebates and similar revenue provisions as contained in H.R. 1, the American Recovery and Reinvestment Act of 2009; and HR 3200 and S. ?, the Affordable Health Choices Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption
NOVO NORDISK INC. via NOVO NORDISK INC.
2010 · first_quarter · Q1
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption
Supporting increasing opportunities for better care and treatment of people with diabetes in H.R. 3200, and S. ?, Affordable Health Choices Act, (entire bill, including Prevention and Wellness titles)
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
NOVO NORDISK INC. via NOVO NORDISK INC.
2009 · fourth_quarter · Q4
Issues related to Medicaid rebates, Public Health Service Act programs, and other revenue provisions contained in H.R. 3200, and H.R. 3926, Affordable Health Care for America Act, H.R. 3590, Patient Protection and Affordable Care Act, S. 1796, America's Healthy Future Act of 2009
H.R. 1402, S. 1473, the Catalyst for Better Diabetes Care Act; H.R. 2590, Preventing Diabetes in Medicare Act; H.R. 2425, Medicare Diabetes Self-Management Training Act; H.R. 3200 and H.R. 3926, Affordable Health Care for America Act, H.R. 3590, Patient Protection and Affordable Care Act, and S. 1796, America's Healthy Future Act of 2009, diabetes provisions
NOVO NORDISK INC. via NOVO NORDISK INC.
2009 · third_quarter · Q3
Issues related to Medicaid rebates and similar revenue provisions as contained in H.R. 1, the American Recovery and Reinvestment Act of 2009; and HR 3200 and S. ?, the Affordable Health Choices Act
H.R. 3148, the Preventive Health Savings Act
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
NOVO NORDISK INC. via NOVO NORDISK INC.
2009 · second_quarter · Q2
Legislation to support more accurate cost-estimating for preventive health care
Supporting increasing opportunities for better care and treatment of people with diabetes in H.R. ?, and S. ?, Affordable Health Choices Act, including the Senate Finance, Senate HELP Committee, and House TriCommittee draft bills (entire bill, including Prevention and Wellness titles)
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption
NOVO NORDISK INC. via NOVO NORDISK INC.
2009 · first_quarter · Q1
Improve the care and treatment of people with diabetes by the creation of a National Diabetes Coordinator; H.R. 1402, the Catalyst for Better Diabetes Care Act; legislation to provide coverage of medical nutrition therapy for people diagnosed with prediabetes in the Medicare program
H.R. 1260 and S. 515, Patent Reform Act of 2009 (entire bill)
Legislation to support more accurate cost-estimating for preventive health care
NOVO NORDISK INC. via NOVO NORDISK INC.
2008 · fourth_quarter · Q4
H.R. 1908 and S. 1145, Patent Reform Act of 2007 (entire bill); S. 3600, Patent Reform Act of 2008
H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness; S. 3101, Medicare Improvements for Patients and Providers Act of 2008, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
NOVO NORDISK INC. via NOVO NORDISK INC.
2008 · third_quarter · Q3
H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness; S. 3101, Medicare Improvements for Patients and Providers Act of 2008, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Issues related to taxation, including extension of the R&D tax credit as contained in H.R. 1424, The Emergency Economic Stabilization Act of 2008
H.R. 1908 and S. 1145, Patent Reform Act of 2007 (entire bill); S. 3600, Patent Reform Act of 2008
NOVO NORDISK INC. via NOVO NORDISK INC.
2008 · second_quarter · Q2
H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
S.3123, Closing the Foreign Lobbying Loophole Act; H.R. 4854, False Claims Corrections Act of 2007
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
NOVO NORDISK INC. via NOVO NORDISK INC.
2008 · first_quarter · Q1
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
H.R. 1908 and S. 1145, Patent Reform Act of 2007 (entire bill)
H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.
NOVO NORDISK INC. via NOVO NORDISK INC.
2007 · year_end · YY
Senate Foreign Relations Committee consideration of relevant international tax treaties
H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Meicaid, and SCHIP Extension Act of 2007; H.R. 2292 and part of S. 1302, Preventing Diabetes in Medicare Act; H.R. 4 and S. 3, Medicare Prescription Drug Price Negotiation Act
S. 1145 and H.R. 1908, Patent Reform Act of 2007
NOVO NORDISK INC. via NOVO NORDISK INC.
2007 · mid_year · MM
Diabetes funding in S. 1710, H.R. 3043, Labor-HHS-Education Appropriations; FDA/Importation provisions in S. 1859, H.R. 3161, Agriculture Appropriations; Importation provision in S. 1644, H.R. 2638, Homeland Security Appropriations;
H.R. 2900, FDA Amendments Act of 2007, PDUFA S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA H.R. 1561, Enhancing Drug Safety and Innovation Act, PDUFA S. 1156, Best Pharmaceutical for Children Amendments of 2007, pediatric provisions
* H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007 H.R. 4, S. 3, Medicare Prescription Drug Price Negotiation Act H.R. 3162, Related Senate amendment, CHAMP Act (SCHIP) 7
NOVO NORDISK INC. via NOVO NORDISK INC.
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Patent & Trademark Office (PTO), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2005 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2005 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2004 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2004 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via NOVO NORDISK INC.
2004 · mid_year · RA
NOVO NORDISK INC. via NOVO NORDISK INC.
2004 · mid_year · RR
FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization
FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation; HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office
H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
H.R. 436 Protect Medical Innovation Act of 2011
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012
H.R. 1249 and S. 23, America Invents Act
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
H.R. 1249 and S. 23, America Invents Act
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization
H.R. 436 Protect Medical Innovation Act of 2011
S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, and the Prevention and Public Health Fund
H.R. 1, Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, and S. 3793, Jobs Creation and Tax Cut Act; and H.R. 3081, Continuing Appropriations Act 2011, issues related to the 340(b) program
H.R. 3148, the Preventive Health Savings Act; H.R. 3663 and S. 3058, To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act; S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011, diabetes-related provisions
H.R. 5175 and S. 3628, Democracy is Strengthened by Casting Light on Spending in Elections (DISCLOSE) Act
H.R. 4853 (P.L. 111-312) Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010, and S. 3793, Jobs Creation and Tax Cut Act, and H.R. 3081, Continuing Appropriations Act 2011, issues related to the 340(b) program
Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009; P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010, including National Diabetes Prevetion Program, National Quality Strategy, and Public Health Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained H.R. 3590, Patient Protection and Affordable Care Act of 2009; H.R. 4872, The Health Care & Education Affordability Reconciliation Act of 2010; H.R. 4872, The Health Care & Education Affordability Reconciliation Act of 2010, H.R.4213 American Jobs and Closing Tax Loopholes Act of 2010, issues related to the 340B program
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; H.R. 1408, Sunshine in Litigation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 3148, the Preventive Health Savings Act
Protecting patient safety in H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Savings Medicine Act; H.R. 1548, Pathway for Biosimilars Act; H.R. 3200, and S. ?, Affordable Health Choices Act, biosimilar provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in H.R. 1, the American Recovery and Reinvestment Act of 2009; and HR 3200 and S. ?, the Affordable Health Choices Act
H.R. 3148, the Preventive Health Savings Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 3148, the Preventive Health Savings Act; S. 1796, America's Healthy Future Act of 2009 and H.R. 3590, Patient Protection and Affordable Care Act, scoring provisions
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009, issues related to federal preemption; H.R. 2502, Comparative Effectiveness Research Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Supporting increasing opportunities for better care and treatment of people with diabetes in H.R. 3200, and S. ?, Affordable Health Choices Act, (entire bill, including Prevention and Wellness titles)
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in H.R. 1, the American Recovery and Reinvestment Act of 2009
H.R. 1260 and S. 515, Patent Reform Act of 2009, entire bill; S. 515 Patent Reform Act; H.R. 1408, Sunshine in Litigation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
Issues related to Medicaid rebates and similar revenue provisions as contained in H.R. 1, the American Recovery and Reinvestment Act of 2009
H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal preemption
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
S.3123, Closing the Foreign Lobbying Loophole Act; H.R. 4854, False Claims Corrections Act of 2007
H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.
H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Issues related to taxation, including extension of the R&D tax credit as contained in H.R. 1424, The Emergency Economic Stabilization Act of 2008
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
S.3123, Closing the Foreign Lobbying Loophole Act; H.R. 4854, False Claims Corrections Act of 2007
H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.
Improve the care and treatment of people with diabetes in H.R. 4836 and S. 2742, the National Diabetes Coordinator Act; H.R. 3544 and S. 2479, Catalyst for Better Diabetes Care Act; H.R. 2922 and S. 1302 (partial), the Preventing Diabetes in Medicare Act; H.R. 2762 and H.R. 1494, Reauthorize Special Diabetes Programs
H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, drug importation provisions.
H.R. 1908 and S. 1145, Patent Reform Act of 2007 (entire bill)
H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007; H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007; H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007; issues relating to comparative effectiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
* Legislation to reduce health disparities, including H.R. 3014, the Healthcare Equity and Accountability Act; and S. 1576, Minority Health Improvement and Health Disparity Elimination Act Protecting patient safety in H.R. 1038 and S. 623, Access to Life-Saving Medicine Act; H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007; S. 1505, Affordable Biologics for Consumers Act of 2007; S. 1695, Biologics Price Competition and Innovation Act of 2007 Legislation to reduce health disparities, including H.R. 3014, the Healthcare Equity and Accountability Act; and S. 1576, Minority Health Improvement and Health Disparity Elimination Act
H.R. 4 and S. 3, Medicare Prescription Drug Price Negotiation Act; S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007; H.R. 3580, Food and Drug Administration Amendments Act of 2007; S. 1082, Prescription Drug User Fee Amendments of 2007; H.R. 2058, Helping Fill the Medicare Rx Gap Act of 2007
H.R. 2638 and S. 1644, Homeland Security Appropriations Act, drug importation provisions; H.R. 3043 and S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, drug importation and diabetes provisions; H.R. 3161 and S. 1859, Agriculture, Rural Development, Food and Drug Administration Appropriations Act, drug importation provisions; H.R. 3093 and S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act; drug importation provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE
* S. 755, Diabetes Screening and Medicaid Savings Act H.R. 2762, S 1494, Reauthorization of Special Diabetes Funding for Type 1 Diabetes and Indians S. 631, Remote Patient Management for Diabetes and Other Chronic Health Care Conditions H.R. 1224, Physical Education Content and Performance Standards in Schools H.R. 2210, Diabetes Prevention Access and Care Act H.R. 2922, Preventing Diabetes in Medicare Act S. 1161, HELP America bill, pre-diabetes medicare provisions H.R. 2241, S. 1391, Diabetes Treatment and Prevention Act S. 242, H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 1038, S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics 5 6
S. 1145, H.R. 1908, Patent Reform Act; PTO continuation practice reforms
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE